Synapse - Maria Vilenchik

Maria Vilenchik

Research Focus

Former Employee. Molecular Pharmacology Program; Research Fellow

Recent additions – View all

Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer
Journal Article

Rodina, A.; Vilenchik, M.; Moulick, K.; Aguirre, J.; Kim, J.; Chiang, A.; Litz, J.; Clement, C. C.; Kang, Y.; She, Y.; more...
Nature Chemical Biology (2007)

Fulltext@MSK | Save
Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90
Meeting Abstract

Chiosis, G.; Vilenchik, M.; Kim, J.; Aguirre, J.; Rosen, N.
Annals of Oncology (2005)

Fulltext@MSK | Save
Combinatorial targeting of oncogenesis via a novel rationally designed Hsp90 inhibitor
Meeting Abstract

Chiosis, G.; Solit, D.; Vilenchik, M.; Rosen, N.
Cancer Research (2004)

Fulltext@MSK | Save

Co-authors at MSK

7

Chiosis
5

Rosen
3

Huezo
3

Kim
3

Solit
2

Aguirre
1

Basso
1

Chiang
1

Clement
1

He
1

Jiang
1

Kang
1

Lucas
1

Massague
1

Moulick
1

Rodina ...
1

She
1

Wu

Types of Work

Publications

Chemistry and Biology (2)
Annals of Oncology (1)
Cancer Research (1)
Drug Discovery Today (1)
Nature Chemical Biology (1)
Proceedings of the American Association for Cancer Research Annual Meeting (1)